This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • LINX Reflux Management System Clinical Study Proto...
Clinical trial

LINX Reflux Management System Clinical Study Protocol

Read time: 1 mins
Last updated:1st Nov 2008

The purpose of the study is to evaluate the safety and effectiveness of the LINX Reflux Management System in the treatment of Gastroesophageal Reflux Disease (GERD).


Study Type: Interventional
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: LINX Reflux Management System Clinical Study Protocol
Enrollment: 100
Study Start Date: November 2008
Study Completion Date: September 2011
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)

Arms:
- Magnetic Sphincter Augmentation


Related journal: Long-Term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal Reflux.

Category Value
Study start date 2008-11-01

View full details